文献速递心脑血管急症消化、代谢与肾脏急症

D-二聚体用于ST段抬高型心肌梗死患者主动脉夹层的筛查

D-dimer for screening of aortic dissection in patients with ST-elevation myocardial infarction.
PubMed 文献 · Am J Emerg Med · 2022-07-16
一句话结论在ADD-RS为1分的STEMI患者中,D-二聚体≥750 ng/mL诊断并发主动脉夹层的灵敏度与阴性预测值均为100%。

本研究为2014至2019年两家三级中心回顾性队列,纳入临床诊断STEMI且到院时检测血清D-二聚体的患者,主要终点为主动脉夹层诊断。322例中28例诊断主动脉夹层;在262例ADD-RS为1分的患者中,D-二聚体诊断主动脉夹层的AUROC为0.970(95%CI 0.948-0.993)。以D-二聚体≥750 ng/mL为界值,灵敏度100%、特异度86.4%、阳性预测值37.7%、阴性预测值100%,209例(79.8%)可据此排除主动脉夹层。作者认为床旁D-二聚体检测采用新界值有助于在STEMI患者中排除主动脉夹层。

要点

  • 在ADD-RS为1分的STEMI患者中,D-二聚体诊断主动脉夹层的AUROC为0.970(95%CI 0.948-0.993)。
  • D-二聚体≥750 ng/mL诊断主动脉夹层并发STEMI的灵敏度100%、特异度86.4%、阳性预测值37.7%、阴性预测值100%。
  • 以D-二聚体<750 ng/mL为界值,262例ADD-RS为1分患者中209例(79.8%)可排除主动脉夹层。
  • 原文指出ADD-RS原采用≥500 ng/mL作为任何疑似主动脉夹层的界值,本研究提出STEMI人群可用750 ng/mL。
  • 作者认为床旁10分钟D-二聚体检测采用新界值有助于在STEMI患者中排除主动脉夹层。

适用人群与场景

  • 临床诊断STEMI且到院时检测血清D-二聚体的患者,来自2014至2019年两家三级中心。
  • 重点分析ADD-RS为1分(低至中度主动脉夹层风险)的患者。

诊断标准与关键阈值

  • 主动脉夹层检测风险评分(ADD-RS)为1分定义为低至中度主动脉夹层风险。
  • D-二聚体≥750 ng/mL作为诊断主动脉夹层并发STEMI的界值,灵敏度100%、特异度86.4%、阳性预测值37.7%、阴性预测值100%。
  • D-二聚体<750 ng/mL可用于排除主动脉夹层,262例中209例(79.8%)符合此标准。
  • 原文指出ADD-RS原采用≥500 ng/mL作为任何疑似主动脉夹层的界值。

研究设计与关键结果

  • 回顾性队列研究,2014至2019年两家三级中心,共纳入322例临床诊断STEMI且到院检测血清D-二聚体的患者,28例诊断主动脉夹层。
  • 在262例ADD-RS为1分的患者中,D-二聚体诊断主动脉夹层的AUROC为0.970(95%CI 0.948-0.993)。
  • 以D-二聚体≥750 ng/mL为界值,诊断主动脉夹层的灵敏度100%、特异度86.4%、阳性预测值37.7%、阴性预测值100%。
  • 以D-二聚体<750 ng/mL为界值,209例(79.8%)患者可排除主动脉夹层。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,床旁D-二聚体检测采用750 ng/mL界值有助于在STEMI患者中排除主动脉夹层。
  • 对ADD-RS为1分的STEMI患者,D-二聚体<750 ng/mL时原文数据显示可排除主动脉夹层(209/262例,79.8%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute aortic dissection (AAD) with concurrent ST-segment elevation myocardial infarction (STEMI) is relatively rare and sometimes overlooked. As D-dimer testing has been reported to have high sensitivity to diagnose AAD in a clinical scale, Aortic Dissection Detection Risk Score (ADD-RS), a point-of-care D-dimer analyzer capable of measuring in 10 min would be useful to deny AAD with concurrent STEMI. However, an optimal cut-off value of D-dimer in such population remains unclear. Therefore, the aim of this study was to elucidate the optimal D-dimer threshold in patients clinically diagnosed with STEMI.

METHODS: This retrospective cohort study was conducted at two tertiary care centers between 2014 and 2019. Patients clinically diagnosed with STEMI who underwent serum D-dimer measurement on hospital arrival were included. The primary outcome was the diagnosis of AAD. The area under the receiver operating characteristic curve (AUROC) for D-dimer values to diagnose AAD was evaluated, particularly in patients with low to moderate risks of AAD (1 of ADD-RS). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated with several cut-off values.

RESULTS: A total of 322 patients were included, and 28 were diagnosed with AAD. The AUROC for D-dimer to diagnose AAD was 0.970 (95% confidence interval: 0.948-0.993) in 262 patients with 1 of ADD-RS. If D-dimer ≥750 ng/mL was used as a cut-off value, sensitivity, specificity, PPV and NPV were 100%, 86.4%, 37.7%, and 100%, respectively. AAD could be denied in 209 (79.8%) patients using the cut-off value (D-dimer <750 ng/mL).

CONCLUSIONS: Serum D-dimer ≥750 ng/mL exhibited high sensitivity and NPV to diagnose AAD with concurrent STEMI, while the ADD-RS originally utilized ≥500 ng/mL as a cut-off for any suspected AAD. A point-of-care D-dimer measurement with the new cut-off would be useful to rule-out AAD among patients with STEMI.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kaito D, Yamamoto R, Nakama R, et al. D-dimer for screening of aortic dissection in patients with ST-elevation myocardial infarction. Am J Emerg Med. 2022. PMID: 35868207. doi:10.1016/j.ajem.2022.07.024

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。